PSIL
AdvisorShares Psychedelics ETF · PSE
- Category Equity
- Expense Ratio 0.99%
- Listing Date Sep 16, 2021
- Volume 51,578.0
- Market Cap (AUM) $7.08M
Performance
-1.56%
1W
-13.73%
1M
-12.5%
3M
-6.67%
6M
-9.35%
YTD
-27.86%
1Y
Top Holdings
-
Name
Symbol%Assets
- Mind Medicine (MindMed), Inc.MNMD16.26%
- Cybin, Inc.CYBN8.98%
- COMPASS Pathways Plc Sponsored ADRCMPS6.91%
- ATAI Life Sciences N.V.ATAI6.05%
- Psyence Biomedical Ltd.PBM5.87%
- GH Research PlcGHRS5.26%
- Intra-Cellular Therapies, Inc.ITCI4.97%
- VistaGen Therapeutics, Inc.VTGN4.96%
- Alkermes Public Limited CompanyALKS4.48%
- MUTUAL FUND (OTHER)N/A4.47%
Technical Analysis of PSIL 2024-05-03
Overview:
In analyzing the technical indicators for PSIL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been relatively stable around the current pric...
Recent News & Updates
- 2022-08-23 20:42
- 2022-04-03 22:30
Best & Worst Performing ETFs Of 2022(Yahoo Finance)
- 2022-02-01 01:30
3rd Psychedelics ETF Launches(Yahoo Finance)
- 2021-11-03 02:15
ETFs & Innovation Go Hand In Hand(Yahoo Finance)
- 2021-10-17 20:35
- 2021-09-30 19:30
- 2021-09-22 19:30
- 2021-09-20 21:45
- 2021-09-19 19:50
Page 1 of 1
previousnext